iifl-logo-icon 1
iifl-logo-icon 1
iifl-logo-icon 1
Home

Abbott India Ltd Share Price

₹27,598.15
(-0.06%)
Jul 3, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹27,700
  • Day's High₹27,839.35
  • 52 Wk High₹29,638.95
  • Prev. Close₹27,614.9
  • Day's Low₹27,479.4
  • 52 Wk Low ₹22,000
  • Turnover (lac)1,494.99
  • P/E48.89
  • Face Value₹10
  • Book Value₹2,065.77
  • EPS565.28
  • Mkt. Cap (Cr.)₹58,646.07
  • Div. Yield1.48
Loading...
  • Open₹27,625.9
  • Day's High₹27,850
  • Spot₹27,377.45
  • Prev. Close₹27,666.65
  • Day's Low₹27,201.75
  • ViewLong Unwinding
  • Market Lot20
  • OI(Chg %)-10,360 (-78.72%)
  • Roll Over%20
  • Roll Cost0.37
  • Traded Vol.23,440 (-44.32%)
View More Futures

Abbott India Ltd KEY RATIOS

Sector

Pharmaceuticals

CMP
as on 03 Jul, 2024 12:00:00 AM

₹27,598.15 --0.06 --16.75

Open

₹27,700

Prev. Close

₹27,614.9

Turnover(Lac.)

₹1,494.99

Day's High

₹27,839.35

Day's Low

₹27,479.4

52 Week's High

₹29,638.95

52 Week's Low

₹22,000

Book Value

₹2,065.77

Face Value

₹10

Mkt Cap (₹ Cr.)

58,646.07

P/E

48.89

EPS

565.28

Divi. Yield

1.48

Abbott India Ltd Corporate Action

29 Apr 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

19 May 2023

12:00 AM

AGM

Announcement Date: 19 May, 2023

arrow

19 May 2023

12:00 AM

Dividend

Dividend Amount: 180

Record Date: 21 Jul, 2023

arrow

Abbott India Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Abbott India Ltd SHAREHOLDING SNAPSHOT

03 Jul, 2024|11:55 PM
Mar-2024Dec-2023Sep-2023Jun-2023
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 74.98%

Foreign: 74.98%

Indian: 0.00%

Non-Promoter- 9.08%

Institutions: 9.08%

Non-Institutions: 15.92%

Custodian: 0.00%

Read More
Share Price

Abbott India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

21.25

21.25

21.25

21.25

Preference Capital

0

0

0

0

Reserves

3,167.29

2,798.54

2,580.91

2,410.45

Net Worth

3,188.54

2,819.79

2,602.16

2,431.7

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

4,919.27

4,310.02

4,093.14

3,298.5

yoy growth (%)

14.13

5.29

24.09

13.64

Raw materials

-2,657.21

-2,390.92

-2,315.65

-1,904.74

As % of sales

54.01

55.47

56.57

57.74

Employee costs

-579.46

-492.65

-476.1

-393.69

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

1,079.73

925.95

802.69

621.48

Depreciation

-66.1

-58.13

-59.6

-16.18

Tax paid

-281.03

-235.26

-209.75

-220.26

Working capital

201.35

142.23

751.83

336.01

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

14.13

5.29

24.09

13.64

Op profit growth

18.04

21.81

44.22

32.01

EBIT growth

16.37

16.39

29.73

42.59

Net profit growth

15.63

16.48

47.78

45.02

View Ratios

No Record found

View Annually Results

Abbott India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,525.25

120.293,65,682.64867.60.895,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,574.25

76.971,21,312.55310.662,259507.93

Cipla Ltd

CIPLA

1,488.95

32.361,20,195.021,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,104

31.351,08,114.811,405.20.283,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,430

24.481,06,298.051,034.80.635,081.81,453.02

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Abbott India Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

Munir Shaikh

Non Executive Director

Kaiyomarz Marfatia

Non Executive Director

Ambati Venu

Independent Director

Anisha Motwani

Independent Director

Sudarshan Jain

Independent Director

Shalini Kamath

Non Executive Director

Sabina Ewing

Managing Director

Vivek Vasudev Kamath

Director

Mahadeo Karnik

Registered Office

Tel: -

Website: -

Email: -

Registrar Office

Tel: -

Website: -

Email: -

Reports by Abbott India Ltd

Summary

Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country. The Company sells its products through independent distributors primarily within India. It provides products and solutions across various therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc. Its global products include Brufen, Prothiaden, Thyronorm and Leptos.The company has four divisions. The Primary Care division markets products in the areas of pain management and gastroenterology. The Specialty Care-Methabolics and Urology division provides solutions in the areas of thyroid, obesity, diabetes and benign prostatic hyperplasia. The Specialty Care-Neuroscience division has a varied portfolio with specialty products in neurology and psychiatric segments. Hospital Care offers products in the field of anesthesiology and neonatology, such as Forane, Sevorane and Survanta.Abbott India Ltd was originally incorporated on August 22, 1944 as Boots Pure Drug Company (India) Ltd. The company name was changed to The Boots Company (India) Ltd on November 1, 1971, thereafter to Boots Pharmaceuticals Ltd on January 1, 1991. In October 31, 1995 the name was changed to Knoll Pharmaceuticals Ltd, and in July 1, 2002, they got their present name Abbott India Ltd.In the year 200
Read More

Company FAQs

What is the Abbott India Ltd share price today?

Down Arrow

The Abbott India Ltd shares price on nse is Rs.₹27598.15 today.

What is the Market Cap of Abbott India Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Abbott India Ltd is ₹58646.07 Cr. as of 03 Jul ‘24

What is the PE and PB ratio of Abbott India Ltd?

Down Arrow

The PE and PB ratios of Abbott India Ltd is 48.89 and 15.88 as of 03 Jul ‘24

What is the 52 Week High and Low of Abbott India Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Abbott India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Abbott India Ltd is ₹22000 and ₹29638.95 as of 03 Jul ‘24

What is the CAGR of Abbott India Ltd?

Down Arrow

Abbott India Ltd's CAGR for 5 Years at 25.75%, 3 Years at 18.10%, 1 Year at 18.78%, 6 Month at 18.38%, 3 Month at 1.22% and 1 Month at 6.45%.

What is the shareholding pattern of Abbott India Ltd?

Down Arrow

The shareholding pattern of Abbott India Ltd is as follows:
Promoters - 74.99 %
Institutions - 9.09 %
Public - 15.93 %

QUICKLINKS FOR Abbott India Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.